Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study to Evaluate FluMist in Immunocompromised Children
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study
- Status
- COMPLETED
- Phase
- PHASE2
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
- Status
- COMPLETED
- Phase
- PHASE3
Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
- Status
- TERMINATED
- Phase
- PHASE3
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
- Status
- UNKNOWN
- Phase
- PHASE4
Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life
- Status
- COMPLETED
- Phase
- NA
OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3